نتایج جستجو برای: lupus nephritis

تعداد نتایج: 48655  

Journal: :international journal of preventive medicine 0
nilofar hajizadeh faezeh javadi laijani mastaneh moghtaderi nematollah ataei farahnak assadi

chronic kidney disease is one of the most common complication of systemic lupus erythematosus, which if untreated can lead to  the end-stage renal disease (esrd). early diagnosis and adequate treatment of lupus nephritis (ln) is critical to prevent the chronic kidney disease incidence and to reduce the development of esrd. the treatment of ln has changed significantly over the past decade. in p...

Journal: :The Egyptian journal of immunology 2014
Samah A Elshweikh Radwa M Elkhouly Mohamed M Shaalan Safinaz H Shorbagy

Renal involvement is common in systemic lupus erythematosus (SLE). Anti-C1q antibodies are associated with SLE nephritis. This study attempted to correlate anti-C1q levels to different types of lupus nephritis (LN). Anti-C1q antibodies were assessed in two groups (15 subjects each) of SLE patients with and without LN. Ten apparently healthy volunteers served as controls. The sensitivity of anti...

Journal: :Nephron 2002
Jorge Isaac Fuad S Shihab

Lupus glomerulonephritis is a common and serious complication of systemic lupus erythematosus (SLE) affecting up to 50% of lupus patients. Recurrent lupus nephritis is rare, complicating as low as 1% of the lupus transplant population according to some authors. However, it may be underreported with more realistic recurrent rates oscillating from 2.8 to 8.7%. We report the case of a patient with...

2011
Shih-Han S. Huang Ainslie Hildebrand William F. Clark

Lupus nephritis leads to significant morbidity and mortality in patients with systemic lupus erythematous. Immunosuppressive agents are recommended in management of Class III, IV and V lupus nephritis. The goals of therapy are to control the disease and to prevent relapse while minimizing side-effects of therapy. Most of the evidences in managements of Class III and IV lupus nephritis comes fro...

2016
Satish Kumar Khader Valli Rupanagudi

Lupus nephritis is a frequent complication of systemic lupus erythematosus. Multiple pathological mechanisms attribute to the pathogenesis of lupus nephritis. These mechanisms can be grossly divided into two groups, extrarenal or intrarenal pathways. A variety of genetic variants break immune tolerance to nuclear autoantigens, as evident from the existence of antinuclear antibodies. Furthermore...

2017
Takashi Iijima Junichi Hoshino Kenmei Takaichi Tadashi Kohno Takeshi Fujii Kenichi Ohashi Yoshifumi Ubara

A 48-year-old woman was admitted to our hospital to undergo evaluation for fatigue, severe weight loss, and nephrotic range proteinuria. Light microscopy of a renal biopsy specimen revealed class III (A) lupus nephritis, while immunofluorescence and electron microscopy only showed sparse immune deposits with findings that were not typical of lupus nephritis. Computed tomography revealed a mass ...

Journal: :Bulletin of the NYU hospital for joint diseases 2010
Carlos Franco Wonsuk Yoo Domingo Franco Zeng Xu

UNLABELLED Lupus nephritis is one of the most serious manifestations of systemic lupus erythematosus (SLE). African Americans generally have a more severe presentation and more often progress to end stage renal disease (ESRD) than Caucasians. Several studies point to higher creatinine, low complement levels, thrombocytopenia, anemia, hypertension, and proliferative glomerulonephritis as predict...

Journal: :Arthritis Research & Therapy 2009
Olivier C Meyer Pascale Nicaise-Roland Nolwenn Cadoudal Sabine Grootenboer-Mignot Elisabeth Palazzo Gilles Hayem Philippe Dieudé Sylvie Chollet-Martin

INTRODUCTION Autoantibodies against C1q correlate with lupus nephritis. We compared titers of anti-C1q and anti-dsDNA in 70 systemic lupus erythematosus patients with (n = 15) or without (n = 55) subsequent biopsy-proven lupus nephritis. METHODS The 15 patients with subsequent lupus nephritis had anti-C1q assays during clinical flares (mean Systemic Lupus Erythematosus Disease Activity Index ...

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2013
Brad H Rovin Samir V Parikh Lee A Hebert Tak Mao Chan Chi Chiu Mok Ellen M Ginzler Lai Seong Hooi Paul Brunetta Romeo Maciuca Neil Solomons

Severe lupus nephritis is an aggressive disease that requires an aggressive approach to treatment. Recent randomized clinical trials showed that mycophenolate mofetil compared favorably with cyclophosphamide (traditional approach) for remission induction. Consequently, mycophenolate mofetil is now commonly recommended as first-line therapy. Nevertheless, the role of mycophenolate mofetil in tre...

2011
Katsuhisa Miyake Mitsuteru Akahoshi Hitoshi Nakashima

Lupus nephritis, which has various histological patterns and variable clinical outcomes, is one of the most important complications of systemic lupus nephritis (SLE). This pathogenetic mechanism in each histologically different type of lupus nephritis (LN) remains unclear. Although SLE is suggested to be a Th2-driven disease, elevation of both Th1 and Th2 cytokines occurs in both humans and mic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید